newsfilter
← Latest News
Business Wire·

VBI Vaccines Announces Closing of Underwriters' Partial Exercise of Option to Purchase Additional Common Shares

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI or the Company), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that the underwriters of its recent